Norway· NO-ID_DF662083-706E-48CE-A339-0A22D0933CF1
Nulibry
A fosdenopterin product containing fosdenopterin, registered in Norway by Tmc Pharma (EU) Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Fosdenopterin is registered in 11 of 19 countries.
Countries holding a registration under ATC A16AX19 (fosdenopterin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Fosdenopterin · ATC A16AX19
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Fosdenopterin
- Manufacturer
- Tmc Pharma (EU) Limited
- Country
- Norway (NO)
- ATC code
- A16AX19
- ATC class
- Fosdenopterin
- Defined daily dose
- 63 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_DF662083-706E-48CE-A339-0A22D0933CF1
- no_varenummer5457429.5NOK 21489.5
- gtin5391543420314
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fosdenopterin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNulibry 9.5 mgTMC Pharma (EU)
- CzechiaNULIBRYTMC Pharma (EU) Limited, Waterford
- United KingdomNulibry 9.5mg powder for solution for injection vialsSentynl Therapeutics, Inc.
- IcelandNulibryTMC Pharma (EU) Limited
- PolandNULIBRYTMC Pharma (EU) Ltd.
- SwedenNULIBRY 9,5 mg Pulver till injektionsvätska, lösningTMC Pharma (EU) Limited
- United StatesNulibrySentynl Therapeutics, Inc.
- FinlandNULIBRYTMC Pharma (EU) Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Nulibry
- Liechtenstein · Nulibry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5e8221ee-8cae-457f-85b2-26523dbdf052 GET /v1/drugs/5e8221ee-8cae-457f-85b2-26523dbdf052?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Fosdenopterin",
"merkevare_id": "ID_DF662083-706E-48CE-A339-0A22D0933CF1",
"name_form_strength": "Nulibry pulv til inj væske, oppl 9,5 mg",
"prescription_group": "C"
}See everything about fosdenopterin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.